Market Tracker

03/30 8:15am ET

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.62
Delayed Data
As of Mar 29
 +0.05 / +8.77%
Today’s Change
0.50
Today|||52-Week Range
1.15
+14.81%
Year-to-Date

Today’s Trading

Previous close0.57
Today’s open0.55
Day’s range0.54 - 0.63
Volume1,228,454
Average volume (3 months)386,196
Market cap$47.0M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)-44.44%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-86.78%
P/E ratioNM
Price/Sales14.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc+0.06+1.46%
AMPEAmpio Pharmaceutical...-0.01-1.22%
BLPHBellerophon Therapeu...+0.07+5.00%
NVLSNivalis Therapeutics...+0.02+0.69%
Data as of 03/29/2017

Financials

Last reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.5M
Annual profit (last year)-$26.9M
Net profit margin-1,069.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts